Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phrenic nerve infiltration in fibromyalgia
NCT05792774Phase 4Completed
- Sponsor
- University of Seville
- Start
- Apr 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine in fibromyalgia (FM), sponsored by University of Seville. Started Apr 2023; status: completed.
02
Drugs
bupivacaine
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT05792774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05792774.